J. T. Ulrich

发表

Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17.

J. P. Lloyd, P. Sarin, D. Zimmerman, 1998, AIDS research and human retroviruses.

Cross-neutralizing antibodies in rabbits immunized with HIV-1 gp160 purified from simian cells infected with a recombinant vaccinia virus.

R. Schmitt, B. Morein, J. Mcclure, 1991, AIDS research and human retroviruses.

Monophosphoryl lipid A as an adjuvant. Past experiences and new directions.

J. T. Ulrich, K. Myers, J. Ulrich, 1995, Pharmaceutical biotechnology.

Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial.

E. Rackow, G. McMahon, M. Astiz, 1995, Critical care medicine.

Preparation and characterization of biologically active 6'-O-(6-aminocaproyl)-4'-O-monophosphoryl lipid A and its conjugated derivative.

R. Wang, N. Qureshi, K. Takayama, 1992, Bioconjugate chemistry.

Bacterial lipopolysaccharide acts synergistically with selected macromolecular polyanions to induce MHC-nonrestricted cytotoxic cells.

H. D. Hochstein, J. Wunderlich, J. T. Ulrich, 1991, Immunobiology.

Molecular Adjuvant Agonist of Human C5a Anaphylatoxin as a Response by a Conformationally Biased Induction of an Antigen-Specific CTL

Stephen M. Taylor, W. Cieplak, S. Sanderson, 2000 .

Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration.

J. Ward, J. T. Ulrich, J. Baldridge, 2000, Vaccine.

A Th1-Inducing Adjuvant, MPL®, Enhances Antibody Profiles in Experimental Animals Suggesting It Has the Potential to Improve the Efficacy of Allergy Vaccines

A. Wheeler, J. Marshall, J. T. Ulrich, 2001, International Archives of Allergy and Immunology.

Immunized with Oligomeric gp160 Respiratory Tracts of Mice Intranasally HIV-1 Neutralizing Antibodies in the Genital and

J. Mascola, D. Birx, C. Alving, 1998 .

Development of a localized hemolysis-in-gel assay for Vi antigen: characterization of the Vi-specific PFC response of nude and normal mice.

J. T. Ulrich, J. Lake, N. D. Reed, 1977, Immunological communications.

Immune interferon induction by T-cell mitogens involves different T-cell subpopulations.

H. Johnson, B. G. Smith, D. Archer, 1979, Cellular immunology.

MPL® Immunostimulant: Adjuvant Formulations

J. T. Ulrich, 2000 .

Induction and Characterization of β-Galactosidase in an Extreme Thermophile

G. McFeters, K. Temple, J. T. Ulrich, 1972, Journal of bacteriology.

Enrichment of suppressor T cells by means of binding to monophosphoryl lipid A

P. Baker, P. Stashak, M. Fauntleroy, 1990, Infection and immunity.

3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activities.

C. L. Johnson, L. Taubner, D. Johnson, 1999, Journal of medicinal chemistry.

Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs).

C. L. Johnson, D. Johnson, J. Ward, 1999, Bioorganic & medicinal chemistry letters.

DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL).

N. B. Ray, D. Lodmell, J. T. Ulrich, 2000, Vaccine.

Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL.

S. Szu, A. Fattom, R. Schneerson, 1991, Journal of immunology.

Prophylactic use of monophosphoryl lipid A in patients at risk for sepsis.

D. Rechtman, J. T. Ulrich, K. Myers, 1994, Progress in clinical and biological research.

A study of some biochemical and physiological properties of an extreme thermophile

J. T. Ulrich, J. Ulrich, 1971 .

Monophosphoryl Lipid A as an Adjuvant

J. T. Ulrich, K. Myers, J. Ulrich, 1995 .

Mode of Action of Oxathiin Systemic Fungicides V. Effect on Electron Transport System of Ustilago maydis and Saccharomyces cerevisiae

D. Mathre, J. T. Ulrich, J. Ulrich, 1972, Journal of bacteriology.

Erythromycin uptake and accumulation by human polymorphonuclear leukocytes and efficacy of erythromycin in killing ingested Legionella pneumophila.

M. F. Miller, P. Billing, J. T. Ulrich, 1984, The Journal of infectious diseases.

Adjuvant Activity of Monophosphoryl Lipid A for Nasal and Oral Immunization with Soluble or Liposome-Associated Antigen

S. Michalek, N. Childers, G. Tong, 2000, Infection and Immunity.

HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.

J. Mascola, D. Birx, C. Alving, 1998, Journal of immunology.

Enhanced immunogenicity of a recombinant genital warts vaccine adjuvanted with monophosphoryl lipid A.

F. Holding, M. Watts, G. Leesman, 1998, Vaccine.

Trehalose dimycolate enhances resistance to infection in neutropenic animals

I. Brook, R. Walker, M. Patchen, 1989, Infection and immunity.

Use of thymosin in the treatment of primary immunodeficiency diseases and cancer.

A. Goldstein, J. Rossio, G. Thurman, 1976, The Medical clinics of North America.

Monoclonal antibodies to bovine UDP-galactosyltransferase. Characterization, cross-reactivity, and utilization as structural probes.

N. Shaper, J. H. Shaper, H. Rittenhouse, 1986, The Journal of biological chemistry.

Enzyme-Linked Immunosorbent Assay for Quantitative Detection of Bacillus thuringiensis Crystal Protein

Robert Alan Smith, J. T. Ulrich, 1983, Applied and environmental microbiology.

Immunotherapy with bacterial endotoxins.

M. Mitchell, J. T. Ulrich, J. Rudbach, 1990, Advances in experimental medicine and biology.

Effect of Temperature on the Respiration and Cytochromes of an Extreme Thermophile

G. McFeters, J. T. Ulrich, 1972, Journal of bacteriology.

Use of Monophosphoryl Lipid A as a Prophylactic for Sepsis and Shock

J. Beatty, J. T. Ulrich, J. Rudbach, 1993 .

Induction of an Antigen-Specific CTL Response by a Conformationally Biased Agonist of Human C5a Anaphylatoxin as a Molecular Adjuvant1

Stephen M. Taylor, W. Cieplak, S. Sanderson, 2000, The Journal of Immunology.

Effects of chlorpromazine on antibody production in vitro.

A. Goldstein, J. T. Ulrich, B. G. Simms, 1978, Birth defects original article series.

Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160

J. Mascola, D. Birx, T. Vancott, 1997, Journal of virology.